A Joint Statement from the European Association of Urology Renal Cell Cancer Guidelines Panel and the International Kidney Cancer Coalition: The Rejection of Ipilimumab and Nivolumab for Renal Cancer by the Committee for Medicinal Products for Human Use Does Not Change Evidence-Based Guideline Recommendations

AuthID
 P-00P-VG9
19
Author(s)
Bex, A
·
Bensalah, K
·
Giles, RH
·
Dabestani, S
·
Hofmann, F
·
Hora, M
·
Lam, TB
·
Marconi, L
·
Fernández Pello, S
·
Abu Ghanem, Y
·
Volpe, A
·
Ljungberg, B
·
Escudier, B
·
Tipo de Documento
Letter
Year published
2018
Publicado
in European Urology, ISSN: 0302-2838
Volume: 74, Número: 6, Páginas: 849-851
Indexing
Scopus®
Pubmed®
Google Scholar®
Publication Identifiers
Pubmed: 30201510
SCOPUS: 2-s2.0-85056208512
Source Identifiers
ISSN: 0302-2838
Export Publication Metadata
Lista Marked
 Adicionar à lista Marked
Citações
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

CORE Conference
No information about CORE Rank

During the preprocessing phase, only publications of type 'Proceedings Paper' or 'Proceedings' are automatically processed to identify their CORE Rank.

TIP: If your publication's CORE Rank is missing, you can contact with your institutional manager to have the correct ranking manually added to the record.

Journal Factors
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

Info
At this moment we don't have any links to full text documens.

Um espaço para investigadores e suas Instituições

Links Úteis

Ajuda

© 2026 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service